TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.

H Bonnefoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.